ARUP Laboratories has opened the Innovation Central Laboratory in Salt Lake City to support biotech and pharmaceutical partners in validating technologies and accelerating diagnostic development from concept to commercialization.
The seed funding will support the commercialization of a platform designed to generate biomarker insights from pathology images without laboratory staining.
A multicenter trial published in Clinical Chemistry reports Vitestro’s autonomous phlebotomy system achieved a 94.5% first-stick success rate, with low hemolysis and adverse event rates, in routine clinical settings.
The accreditation covers liver health diagnostics, including Hepatotrack, a molecular diagnostic liquid biopsy that is predictive of acute liver rejection post-liver transplant.
The recommendations focus on using next-generation sequencing to evaluate off-target editing risks and chromosomal integrity.
Lot-to-lot reagent inconsistencies can have significant effects on patient test results.
The collaboration focuses on creating sensitive assays for a common genetic risk factor to guide drug development and clinical trials.
This clinical lab conference spotlight looks at why ADLM 2026 belongs on the radar for CLP readers. From the scientific program to the Clinical Lab Expo, the event offers practical ideas, fresh technology, and real conversations for people working across diagnostics and laboratory medicine. For lab professionals who want useful insight, sharper perspective, and stronger industry connections, this is a smart place to be.